
|
|
Email Print
|
Market Movers
Fibrocell Science, Inc. to Present at the Kaufman Bros. 14th Annual Investor Conference
EXTON, Pa., Aug 25, 2011 (LevelStock.com News) -- Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Company's Chairman and CEO, will be presenting at the Kaufman Bros. 14th Annual Investor Conference to be held on September 7-8, 2011 at the W Hotel New York.
Fibrocell's presentation is scheduled for Wednesday, September 7, at 12:00 p.m. Eastern Time.
The presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at www.fibrocellscience.com.
About Fibrocell Science, Inc.
Fibrocell Science, Inc. (OTCBB: FCSC) is a biotechnology company focused on the development of regenerative cell therapy for aesthetic, medical and scientific applications. Fibrocell Science is committed to advancing the scientific, medical and commercial potential of autologous skin and tissue, as well as its innovative cellular processing technology and manufacturing excellence. For additional information, please visit www.fibrocellscience.com.
About LevelStock.com
We are an investor community and investors relations website specializing in emerging growth stocks in today's Hot Sectors and providing a platform of services for SmallCap, MicroCap, NanoCap Companies.
We encourage everyone to join our social media sites:
Free Subscription For Our Newsletters: http://www.levelstock.com/
FaceBook: http://www.facebook.com/profile.php?id=100000617594244
Twitter: http://twitter.com/levelstock
LevelStock.com is not a registered investment advisor or broker-dealer. The information here is believed to be reliable, but not guaranteed to be accurate by LevelStock.com Please be advised that the information contained may or may not be complete and is solely for informational purposes only. Please read our full disclaimer for complete risks and disclosures http://www.levelstock.com/news.php?viewStory=19
|
|
|
|
| |
 |